Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20088935 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
Condition: Thromboembolism
Intervention: Drug: YM150

Indicates status has not been verified in more than two years